Clinical Trial Update: Autologous Islet Transplantation for Diabetes [EARLY_Phase 1]

View source ↗

Summary

An early-phase trial (Phase 1) is enrolling by invitation for autologous islet transplantation as a treatment for Type 2 diabetes at Shanghai Zhongshan Hospital…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Diabetes Mellitus, Type 2 | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION